Article
Challenges and Reinterpretation of Antibody-Based Research on Phosphorylation of Tyr307 on PP2Ac.
Cell reports - 3 Mar 2020
Mazhar Sahar, Leonard Daniel, Sosa Alejandro, Schlatzer Daniela, Thomas Dafydd, Narla Goutham
Abstract excerpt
Aberrant hyperphosphorylation of the protein phosphatase 2A catalytic subunit (PP2Ac) at Tyr307 has been associated with aggressive disease and poor clinical outcome in multiple cancers. However, the study of reversible phosphorylation at this site has relied entirely upon the use of antibodies-most prominently, the clone E155. Here, we provide evidence that the E155 and F-8 phospho-Tyr307 antibodies cannot...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
